IMBIQ — Legacy IMBDS Share Price
- $0.00m
- $169.59m
- $544.56m
- 35
- 92
- 17
- 46
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -18.38% | ||
Return on Equity | -154.88% | ||
Operating Margin | -8.78% |
Financial Summary
Year End 28th Jan | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 596.64 | 501.82 | 454.17 | 551.13 | 544.55 | 508.1 | 522.42 | -3.43% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Legacy IMBDS, Inc., formerly iMedia Brands, Inc., is a global media company. It owns and operates four television networks, which are ShopHQ, ShopBulldogTV, ShopHQHealth and 123tv. Its flagship network, ShopHQ is a multiplatform interactive television network offering a balanced assortment of name brands to consumers in an engaging and informative shopping environment via television, online and mobile. 123tv is the interactive media company disrupting Germany’s television retailing marketplace with its Dutch auction style live and automated auctions that engages consumers with 123tv’s balanced merchandising mix of compelling products shipped directly to their homes. Bulldog is a men’s shopping and lifestyle television network offering men’s merchandise, entertainment and services. ShopHQHealth is a Health and Wellness focused network that offers an assortment of products and services to address the physical, spiritual, and mental health needs of its customers and their families.
Directors
- Landel Hobbs NEC (58)
- Timothy Peterman CEO (53)
- Eyal Lalo VCH (46)
- Montgomery Wageman CFO (55)
- Jean-Guillaume Sabatier EVP (51)
- Michael Friedman DRC (50)
- Jill Krueger IND (61)
- Lisa Letizio IND (58)
- Darryl Porter IND (58)
- Aaron Reitkopf IND (54)
- Last Annual
- January 28th, 2023
- Last Interim
- January 28th, 2023
- Incorporated
- June 25th, 1990
- Public Since
- June 28th, 1991
- No. of Employees
- 1,096
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 31,644,860

- Address
- 6740 SHADY OAK RD, MINNEAPOLIS, 55344-3433
- Web
- https://www.imediabrands.com/
- Phone
- +1 6129475200
- Contact
- Ken Cooper
- Auditors
- Deloitte & Touche LLP
Upcoming Events for IMBIQ
Similar to IMBIQ
Arion
Pink Sheets on Nasdaq
Avolta AG
Pink Sheets on Nasdaq
bebe stores
Pink Sheets on Nasdaq
Better for You Wellness
Pink Sheets on Nasdaq
BioForce Nanosciences Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 19:13 UTC, shares in Legacy IMBDS are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Legacy IMBDS last closed at $0.00 and the price had moved by -99.98% over the past 365 days. In terms of relative price strength the Legacy IMBDS share price has underperformed the S&P500 Index by -99.98% over the past year.
The overall consensus recommendation for Legacy IMBDS is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreLegacy IMBDS does not currently pay a dividend.
Legacy IMBDS does not currently pay a dividend.
Legacy IMBDS does not currently pay a dividend.
To buy shares in Legacy IMBDS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Legacy IMBDS had a market capitalisation of $0.00m.
Here are the trading details for Legacy IMBDS:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: IMBIQ
Based on an overall assessment of its quality, value and momentum Legacy IMBDS is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Legacy IMBDS is $2.00. That is 1999900% above the last closing price of $0.00.
Analysts covering Legacy IMBDS currently have a consensus Earnings Per Share (EPS) forecast of -$0.49 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Legacy IMBDS. Over the past six months, its share price has underperformed the S&P500 Index by -93.03%.
As of the last closing price of $0.00, shares in Legacy IMBDS were trading -99.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Legacy IMBDS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Legacy IMBDS' management team is headed by:
- Landel Hobbs - NEC
- Timothy Peterman - CEO
- Eyal Lalo - VCH
- Montgomery Wageman - CFO
- Jean-Guillaume Sabatier - EVP
- Michael Friedman - DRC
- Jill Krueger - IND
- Lisa Letizio - IND
- Darryl Porter - IND
- Aaron Reitkopf - IND